Joint inflammation and cartilage destruction may occur uncoupled
- 1 March 1998
- journal article
- review article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 20 (1-2) , 149-164
- https://doi.org/10.1007/bf00832004
Abstract
Chronic arthritis is characterized by a persistent joint inflammation and concomitant joint destruction. Although the joint swelling is a major clinical problem, destruction of bone and cartilage may occur uncoupled to inflammation and it is of utmost importance to fully understand the elements of the destructive process. TNF and IL-1 are considered master cytokines in the process of human RA, with a claimed cascade of TNF inducing most of the IL-1 production. Studies in experimental models revealed that TNF is indeed a pivotal cytokine in joint swelling, yet IL-1 is the dominant cartilage destructive cytokine and its production may occur independent of TNF. This was found with anti-TNF/IL-1 neutralizing antibodies and the observations were recently backed up with similar data in arthritis models in TNF and IL-1 knockout mice. Apart from the absolute level of IL-1, the destructive potential of an arthritis is determined by the balance with regulatory cytokines and anabolic growth factors. IL-4, IL-6, and IL-10 can promote inflammation and tissue fibrosis, yet cartilage destruction is found to be greatly reduced by these cytokines, linked to a range of pathways which can reduce the IL-1 impact on the articular cartilage. Finally, the presence of anabolic growth factors in the inflamed synovium may have a major impact on net destruction. Endogenous transforming growth factor-β (TGF-β) is found in inflamed synovia, but local coadministration of TGF-β further enhanced the degree of synovitis, yet almost fully prevented cartilage damage, providing another example of a major lack of correlation between inflammatory mass and destructive potential. It is suggested that novel therapy in RA patients should not only focus on reduction of outer signs of joint inflammation, but should also include attempts at reduction of cartilage destruction.Keywords
This publication has 56 references indexed in Scilit:
- EFFECT OF INTERLEUKIN 1 AND LEUKAEMIA INHIBITORY FACTOR ON CHONDROCYTE METABOLISM IN ARTICULAR CARTILAGE FROM NORMAL AND INTERLEUKIN-6-DEFICIENT MICE: ROLE OF NITRIC OXIDE AND IL-6 IN THE SUPPRESSION OF PROTEOGLYCAN SYNTHESISCytokine, 1997
- Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)Clinical and Experimental Immunology, 1997
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritisArthritis & Rheumatism, 1995
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences.Annals of the Rheumatic Diseases, 1994
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.The Journal of Experimental Medicine, 1994
- Flare-up of experimental arthritis in mice with murine recombinant IL-1Clinical and Experimental Immunology, 1992
- Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage pannus junctionClinical and Experimental Immunology, 1991